Report of the clinical donor case workshop of the European Association of Tissue Banks annual meeting 2012
- PDF / 213,033 Bytes
- 10 Pages / 547.087 x 737.008 pts Page_size
- 28 Downloads / 144 Views
ORIGINAL PAPER
Report of the clinical donor case workshop of the European Association of Tissue Banks annual meeting 2012 Hilde Beele • Marja J. van Wijk • Robert Parker • Jacinto Sa´nchez-Iba´nˇez Scott A. Brubaker • Birgit Wulff • Cornelia D. Richters • Mike Cox • Ruth M. Warwick • Ted Eastlund
•
Received: 16 August 2013 / Accepted: 18 September 2013 / Published online: 1 October 2013 Springer Science+Business Media Dordrecht 2013
Abstract The European Association of Tissue Banks (EATB) donor case workshop is a forum held within the program of the EATB annual congress. The workshop offers an opportunity to discuss and evaluate approaches taken to challenging situations regarding donor selection, it promotes consensus development in deciding tissue donor acceptability when donor health issues are not addressed in standards and regulations, and serves to strengthen the professional tissue banking networks across Europe and beyond. This report reflects some of the discussion at the workshop during the annual congress
Robert Parker: Heart Valve Bank, Royal Brompton Hospital, London, UK (retired). H. Beele (&) Tissue Bank, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium e-mail: [email protected] M. J. van Wijk BISLIFE Foundation, Leiden, The Netherlands R. Parker London, UK J. Sa´nchez-Iba´nˇez Regional Transplant Coordination Office Galicia, Santiago, Spain S. A. Brubaker American Association of Tissue Banks, McLean, VA, USA
in Vienna in 2012. The cases presented dealt with problems encountered by tissue bank facilities concerning idiopathic thrombocytopenia and autoimmune disorders, hemodilution and blood sample identification, premalignant and malignant lesions, and Huntington’s disease. The discussions during the workshop demonstrate that the implications on the safety of tissue transplantation of various tissue donor illnesses, physical findings and behaviours, and the preventive measures taken by tissue facilities, may not always be agreed by tissue facility medical directors and other professionals. Moreover, they reveal that operating procedures, regulations and standards cannot comprehensively cover all tissue donor findings, medical histories and circumstances surrounding the B. Wulff Institute of Legal Medicine, UMC Hamburg, Hamburg, Germany C. D. Richters Division Euroskinbank, EuroTissueBank, Beverwijk, The Netherlands M. Cox Danish Health and Medicine Agency, Copenhagen, Denmark R. M. Warwick University of Bristol, Bristol, UK T. Eastlund University of New Mexico, Albuquerque, NM, USA
123
562
cause of death. For many of the issues raised, there is a need for scientific research to provide a better evidence base for future deliberations about the suitability and eligibility of tissue allograft donors. Keywords Tissue donor selection Tissue donor suitability Disease transmission Tissue transplantation Idiopathic thrombocytopenia Hemodilution Huntington’s disease Malignancies
Introduction The European Association of Tissue Banks (EATB), serves its members in many
Data Loading...
